Multiple sclerosis (MS) is a neurological, chronic and progressive disease that results from collection of environmental, genetic and autoimmune factors. The disease, commonly affects people between the age of 20 and 50 years. Common symptoms of MS, which will greatly reduce the quality of life is sleep disorders and poor quality of sleep. Acupressure as a branch of acupuncture is non-pharmacological approach that use in relieving some symptoms including quality of sleep. Therefore, this randomized controlled trial will determine the effect of acupressure on quality of sleep in women with MS. The subjects of this clinical trial (The women with the age of 20-50 years old, the sleep quality score should be 5 or more, Ability for reading and writing) randomly assign into the acupressure group (n=50), which receive acupressure at the true point (shen-men), or the placebo group (n=50), which receive touching instead of acupressure at placebo point. Quality of sleep is main outcome that measure in both groups before and after intervention with Pittsburgh Scale. The women who do not continue the trial for any reason, or the participants who do not feel the heavy and numbness during the intervention at the shen-men point or women that do not perform intervention for more than three nights will be excluded. In the experimental group, participants will be trained for the intervention (acupressure) which is pressing about five minutes at Shen-men point for each side of the body once at night for four consecutive weeks by themselves. The similar procedure that is touching beside of Shen-men point will be implemented for the placebo group.